Telegraph Hill Partners’s AtriCure ATRC Stock Holding History

Telegraph Hill Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-48,494	Closed	-$994K	–	2
2015 Q1	$994K	Sell	48,494 -168,013	-78%	-$3.26M	1.32%	2
2014 Q4	$4.32M	Buy	+216,507	New	+$3.72M	4.5%	2

Other funds holding ATRC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Telegraph Hill Partners's ATRC Position: Q2 2015 in Review

Telegraph Hill Partners sold out of AtriCure (ATRC) in Q2 2015, closing a stake of 48,494 shares — an estimated $994K sold.

Telegraph Hill Partners first reported a position in ATRC in Q4 2014 and held it in 2 quarters. The position peaked at $4.32M in Q4 2014. 111 funds tracked by Wall St. Rank hold ATRC as of Q2 2015.

Telegraph Hill Partners reported no remaining AtriCure position as of Q2 2015 after selling out during the quarter.
Telegraph Hill Partners sold 48,494 AtriCure shares in Q2 2015, an estimated $994K.
Telegraph Hill Partners first reported a position in AtriCure in Q4 2014 and held it in 2 quarters.
Telegraph Hill Partners's AtriCure position peaked at $4.32M in Q4 2014.
111 funds tracked by Wall St. Rank held AtriCure as of Q2 2015.

Based on Telegraph Hill Partners's 13F filing for Q2 2015, filed 28 Jul 2015.